Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18550023.
- Also identified by DOI 10.1016/j.ajog.2008.04.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recurrent/metastatic endometrial adenocarcinoma that is not amenable to cure with local or regional therapy and/or chemotherapy represents a discouraging clinical entity for the clinician. We report the case of 58-year-old woman with recurrent endometrial carcinoma that was resistant to chemotherapy that was treated successfully with the aromatase inhibitor anastrozole.
Medical subject headings
- Adenocarcinoma
- Aromatase Inhibitors
- Endometrial Neoplasms
- Neoplasm Recurrence, Local
- Nitriles
- Triazoles